Good morning :)
$
₹
West Pharmaceutical Services Inc

West Pharmaceutical Services Inc

WST

NYSE
Asset Logo

West Pharmaceutical Services Inc

WST

NYSE
$362.131.21% (-4.46)
$
₹
$362.131.21% (-4.46)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Large Cap

With a market cap of $25.5B the stock is ranked 531

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

46.71
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

8.59
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$7.75
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

2.76
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

16.98%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.24%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 13 analysts' reports

Buy
12 analysts
Hold
1 analyst
Sell
0 analyst

Analysts expect a +11.89% price upside over the next year

Current Price$362.13
Target Price$405.37

Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Peers

Peers

Medline Inc. Class A Common Stock
MDLN
M
P/E Ratio
40.23
40.23
1Y Return
22.82%
22.82%
Buy Reco %
—
—
Align Technology Inc
ALGN
Align Technology Inc
P/E Ratio
25.5
25.5
1Y Return
12.92%
12.92%
Buy Reco %
61.11
61.11
The Cooper Companies, Inc
COO
The Cooper Companies, Inc
P/E Ratio
18.32
18.32
1Y Return
20.00%
20.00%
Buy Reco %
57.89
57.89
Lantheus Holdings Inc
LNTH
Lantheus Holdings Inc
P/E Ratio
24.05
24.05
1Y Return
95.01%
95.01%
Buy Reco %
92.30
92.30
MiniMed Group, Inc. Common Stock
MMED
M
P/E Ratio
—
—
1Y Return
8.94%
8.94%
Buy Reco %
—
—

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
West Pharmaceutical Services Inc 46.718.592.76
Medline Inc. Class A Common Stock40.232.43-
Align Technology Inc25.52.460.61

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

804.3
140
805
132.1
844.9
138.8
872.3
154
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue695.3702746.9748.5698.2766.2804.3805844.9872.3
Net Income115.3111.3136130.189.8131.8140132.1138.8154
Net Profit Margin16.58%15.85%18.20%17.38%12.86%17.20%17.40%16.40%16.42%17.65%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. West Pharmaceutical Services Inc (WST) share price today is $362.13 as of September 19, 2026 at 1:30 AM IST. The stock touched a day high of $367.10 and a day low of $359.63.

  2. West Pharmaceutical Services Inc stock trades on NYSE under the ticker symbol WST.

  3. West Pharmaceutical Services Inc's market capitalization is $25.47B as of September 19, 2026 at 1:30 AM IST.

  4. West Pharmaceutical Services Inc's price-to-earnings (P/E) ratio is 46.71 as of September 18, 2026.

  5. West Pharmaceutical Services Inc's price-to-book (P/B) ratio is 8.59 as of September 18, 2026.

  6. Yes, West Pharmaceutical Services Inc pays a dividend, with a current dividend yield of 0.24%.

  7. Yes, You can buy West Pharmaceutical Services Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy West Pharmaceutical Services Inc shares in three steps: 1. Search West Pharmaceutical Services Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since West Pharmaceutical Services Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in West Pharmaceutical Services Inc (WST) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0276 shares at the current price of $362.13.

Loading...